The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2016
Filed:
Sep. 04, 2013
Applicant:
Alfacyte, Ltd., Milngavie, Glasgow, GB;
Inventor:
William Stimson, Glasgow, GB;
Assignee:
ALFACYTE LTD., Glasgow, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/21 (2006.01); A61K 39/35 (2006.01); A61K 39/39 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/212 (2013.01); A61K 39/35 (2013.01); A61K 39/39 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/57 (2013.01); A61K 2039/577 (2013.01);
Abstract
A method is provided for the treatment and/or prophylaxis of a condition where an enhancement of a Th1-mediated immune response and suppression of a Th2/Th17-mediated immune response are desired. The method comprises the step of administering to a subject in need thereof a therapeutically effective amount of at least one interferon alpha subtype selected from IFN-α10, IFN-α14, and a hybrid thereof. The condition to be treated may be selected from the group consisting of an autoimmune disease, an inflammatory disease (e.g. inflammatory bowel disease) and allergy or an associated allergic condition.